Brasília – Starting this Friday (15), Brazil’s Unified Health System (SUS) will offer a 100% nationally developed molecular biology DNA-HPV test for the early detection of cervical cancer.

The innovative method can identify 14 genotypes of the human papillomavirus (HPV), allowing detection before lesions or early-stage cancer appear, including in asymptomatic women.

According to the Ministry of Health, the test will initially be available in 11 Brazilian states, in addition to the Federal District: Rio de Janeiro, São Paulo, Minas Gerais, Ceará, Bahia, Pernambuco, Pará, Rondônia, Goiás, Rio Grande do Sul, and Paraná.

Source: Ministry of Health

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com